Download MendeleySAR Exploration Guided by LE and Fsp(3): Discovery of a Selective and Orally Efficacious ROR gamma Inhibitor
Hirata, K., Kotoku, M., Seki, N., Maeba, T., Maeda, K., Hirashima, S., Sakai, T., Obika, S., Hori, A., Hase, Y., Yamaguchi, T., Katsuda, Y., Hata, T., Miyagawa, N., Arita, K., Nomura, Y., Asahina, K., Aratsu, Y., Kamada, M., Adachi, T., Noguchi, M., Doi, S., Crowe, P., Bradley, E., Steensma, R., Tao, H., Fenn, M., Babine, R., Li, X., Thacher, S., Hashimoto, H., Shiozaki, M.(2016) ACS Med Chem Lett 7: 23-27
- PubMed: 26819660
- DOI: https://doi.org/10.1021/acsmedchemlett.5b00253
- Primary Citation of Related Structures:
5AYG - PubMed Abstract:
A novel series of RORγ inhibitors was identified starting with the HTS hit 1. After SAR investigation based on a prospective consideration of two drug-likeness metrics, ligand efficiency (LE) and fraction of sp(3) carbon atoms (Fsp(3)), significant improvement of metabolic stability as well as reduction of CYP inhibition was observed, which finally led to discovery of a selective and orally efficacious RORγ inhibitor 3z.
Organizational Affiliation:
Chemical Research Laboratories, Biological Pharmacological Research Laboratories, Drug Metabolism & Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc. , 1-1, Murasaki-cho, Takatsuki, Osaka 569-1125, Japan.
